Browse Related Topics For:

ANDA

126
Patents
106
Pharmaceutical
78
Patent Litigation
76
Generic Drugs
76
Pharmaceutical Patents
61
Patent Infringement
52
Pharmaceutical Manufacturers
45
FDA
45
Prescription Drugs
31
Hatch-Waxman
29
Reverse Payment Settlement Agreements
26
FTC
23
FTC v Actavis
23
SCOTUS
20
Biotechnology
18
Mylan Pharmaceuticals
15
Actavis Inc.
15
Infringement
13
Obviousness
13
Teva Pharmaceuticals
12
Apotex
11
Patent-in-Suit
10
Antitrust Litigation
10
Pay-For-Delay
10
Pfizer
10
Watson Pharmaceuticals
9
Claim Construction
9
Drug Manufacturers
8
Jurisdiction
8
Merck
7
Cephalon
7
Labeling
6
AstraZeneca
6
FDCA
6
Prior Art
6
Sandoz
5
Appeals
5
Popular
4
BPCIA
4
DaimlerAG
4
Eli Lilly
4
Generic
4
Motion to Dismiss
4
Novartis
4
Personal Jurisdiction
4
Safe Harbors
4
Settlement
4
Sherman Act
3
Allergan Inc
3
Amgen
3
Anti-Competitive
3
Antitrust Provisions
3
Biosimilars
3
DaimlerChrysler v Bauman
3
Induced Infringement
3
Intellectual Property Litigation
3
Life Sciences
3
Manufacturers
3
Medicare Modernization Act
3
Par Pharmaceutical
3
Patent Trial and Appeal Board
3
Takeda Pharmaceuticals
3
Written Descriptions
2
AbbVie
2
Antitrust Investigations
2
Biologics
2
Bristol-Myers Squibb
2
Cadence Pharmaceuticals Inc.
2
Certiorari
2
Citizen Petitions
2
Class Action
2
Classen Immunotherapies
2
Corporate Counsel
2
Declaratory Judgments
2
Disgorgement
2
Elan Pharmaceuticals
2
Enablement Inquiries
2
Failure To Warn
2
Forum
2
GlaxoSmithKline
2
Medical Devices
2
Noninfringement
2
Orange Book
2
Orphan Drugs
2
Patent Applications
2
Preliminary Injunctions
2
Product Hopping
2
Prometheus
2
RanBaxy
2
Spectrum v Sandoz
2
Subject Matter Jurisdiction
2
Trademarks
2
USPTO
1
Administrative Procedure Act
1
Advertising
1
Allergan v. Barr Laboratories
1
Amazon
1
Ambiguous
1
Arbitration
1
Arbitration Agreements
1
Bausch & Lomb
1
Bayer
1
Biopharmaceutical
1
Brand
1
Burden of Proof
1
CA Supreme Court
1
Carve Out Provisions
1
Certifications
1
Chevron Deference
1
Chilcott v Teva
1
Cipro
1
Claim Preclusion
1
Claims Limitations Period
1
Clear and Convincing Evidence
1
Clinical Trials
1
Combination Products
1
Competition
1
Complex Litigation
1
Consent Order
1
Contract Drafting
1
Copaxone
1
Copyright
1
Counterclaims
1
Crestor
1
Daiichi Sankyo
1
Damages
1
Duty to Deal
1
E-Filing
1
Exclusivity
1
Exemptions
1
Expert Testimony
1
Expert Witness
1
Fair Market Value
1
FDASIA
1
Federal Jurisdiction
1
Federal Rule 12(b)(6)
1
FENTORA
1
First Amendment
1
Forest Laboratories
1
Fresenius
1
Genzyme
1
Gilead Sciences
1
Good Faith
1
Government Investigations
1
Healthcare
1
HHS
1
Hoffman LaRoche
1
Indefiniteness
1
Information Reports
1
Innovation Act
1
Integra
1
Inter Partes Reexamination
1
Inter Partes Review Proceedings
1
International Arbitration
1
ITC
1
Janssen Pharmaceuticals
1
Jazz Pharmaceuticals
1
Judge Stark
1
Judgment on the Pleadings
1
Justiciable Controversy
1
King Drug Co. of Florence
1
Lanham Act
1
Lipitor
1
Manufacturing Facilities
1
Marketing
1
Medicare
1
Mensing
1
Method-of-Use
1
Minimum Contacts
1
Misbranding
1
New Guidance
1
Noerr-Pennington Doctrine
1
Non-Disclosure Agreement
1
Off-Label Promotion
1
Off-Label Use
1
Par/Paddock
1
PATENT Act
1
Patent Invalidity
1
Patent Reform
1
Patent-Eligible Subject Matter
1
Patients
1
Pharmacies
1
Pleadings
1
PLIVA v Mensing
1
Preemption
1
Presumption of Validity
1
Product Exclusivity
1
Product Labels
1
Proposed Legislation
1
Proposed Regulation
1
Public Meetings
1
Purdue Pharma
1
Real Party in Interest
1
Reissue Patents
1
Remand
1
REMS
1
Research Tools
1
Restrictive Covenants
1
Reversal
1
Reverse Payments
1
Rosuvastatin
1
Royalties
1
Rule-of-Reason Analysis
1
Rulemaking Process
1
Sales Contracts
1
Sandoz v Amgen
1
SmithKline Beecham
1
Split of Authority
1
Standard of Proof
1
Standards-Essential Patents
1
Startups
1
Subsidiaries
1
Summary Judgment
1
The Consumer Relief Fund
1
Trade Secrets
1
TRO
1
Unfair Competition
1
Vaccinations
1
Warner Chilcott
1
Wyeth